InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-05 · accession 0001773751-24-000344 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-07 2024-11-05 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $2.43 +188.9K 255.9K +282% +$459.0K
DM 2024-11-07 2024-11-05 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $20.88 -188.9K 67.0K -74% -$3.94M
DMI 2024-11-07 2024-11-05 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $20.61 -144.4K 519.0K -22% -$2.98M
D 2024-11-07 2024-11-05 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -188.9K 204.0K -48% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-11-05 M A 188,888 $2.43 255,903 D — —
2 Common Class A Common Stock 2024-11-05 S D 63,798 $20.05 192,105 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.54 - $20.53. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Common Class A Common Stock 2024-11-05 S D 99,987 $21.19 92,118 D — — (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.55 - $21.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4 Common Class A Common Stock 2024-11-05 S D 12,402 $21.76 506,602 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — — (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.55 - $22.11. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Common Class A Common Stock 2024-11-05 S D 25,103 $21.76 67,015 D — — (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.55 - $22.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
6 Common Class A Common Stock 2024-11-05 S D 81,114 $20.07 569,932 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.54 - $20.53. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
7 Common Class A Common Stock 2024-11-05 S D 50,928 $21.19 519,004 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — — (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.55 - $21.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
8 Derivative Stock Option (right to buy) 2024-11-05 M D 188,888 $0.00 204,016 D $2.43 · — to 2030-06-17 188,888 Class A Common Stock (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.